• Conference Coverage
    Gastrointestinal Cancers Symposium
    Jan. 17-19, 2019
    San Francisco, CA

    Reach global experts with insights into the latest research in gastrointestinal cancer care.
  • Conference Coverage
    16th Annual Winter Lung Cancer Conference
    Jan. 25-27, 2019
    Miami, FL

    Connect with lung cancer experts and gain insights into cutting edge research and techniques.
  • Conference Coverage
    STS 55th Annual Meeting & Exhibition
    Jan. 27-29, 2019
    San Diego, CA

    Gain expert-driven insights from the top experts in cardiothoracic surgery.
  • Conference Coverage
    International Symposium on Endovascular Therapy
    Jan. 27-30, 2019
    Hollywood, FL

    Gain deep insights from industry-leading experts in the endovascular therapy space.
  • Conference Coverage
    SCCM 48th Critical Care Congress
    Feb. 17-20, 2019
    San Diego, CA

    Elevate your brand with research from industry experts with the latest developments in critical care.
  • Conference Coverage
    ASCO-SITC
    Feb. 28-March 2, 2019
    San Francisco, CA

    Gather insights from industry-leading experts in the clinical immuno-oncology space.
  • Conference Coverage
    23rd Annual International Congress on Hematologic Malignancies
    Feb. 28-March 3, 2019
    Miami, FL

    Strengthen your brand with research from top hematology influencers.
SYNDICATED STUDIES
OUR JOURNAL
Products & Service
Custom Market Research
Custom Market Research
Using a collaborative approach with unmatched benefits. HRA utilizes the full strength and expertise of the MJH enterprise to the service of our clients in consultative custom market research.
Pulse Research
Pulse Research
The pulse program offers timely insights drawn from our panel of more than 20,000 healthcare professionals.
Strategic Syndicated Research
Strategic Syndicated Research
HRA leverages their expertise to publish new reports regularly in different therapeutic and industry areas that are affecting healthcare. These studies gather data on industry trends and evolutions, which provide a baseline from which to build a more in-depth study.
HealthAdviser Panel
HealthAdviser Panel
HealthAdviser is a growing community of healthcare experts who share opinions and insights through participation in focus groups, one-on-one interviews, and online surveys.
Conference Research
Conference Research
HRA conducts qualitative and quantitative research at more than 90 conferences each year, including several "exclusive" events conducted by our large enterprise. HRA offers their clients rapid, front-line results by asking their target audience strategic questions across all phases of their product's life cycle.
Digital Landscape Analysis
Digital Landscape Analysis
With more than two billion people actively engaged in online conversations, social media has the power to - and has - change the face of governments, shaped policy, lifted and/or killed brands and reputations. HRA has deep experience in employing social media and other digital data points to set the stage for everything from data-driven creative used in marketing to competitive intelligence. HRA often uses digital landscape assessments around conference work to surface key themes and opinions about the latest research, drugs, protocols, or positions. Social also blends well with and guide qualitative and quantitative studies.
Webinars & Analytics
How will precision medicine impact the cardiovascular field? Listen into our interactive webinar to learn more.
Are outcome-based contracts the key to swift adoption of your pharmaceutical to formularies? HRA® investigated the payer perspective on whether these contacts will shift pharmaceutical spending to more effective drugs. Listen into our interactive webinar to learn more!
As therapies like Kymriah and Yescarta transform medicine, how can you assist in swift uptake of these treatments or ensure success in the development of yours? Listen into HRA®'s upcoming webinar to discuss the challenges and how to combat them.
An HRA® Publication
Pear-004 may help fill treatment gaps for patients with schizophrenia.
 
The FDA and other regulators must navigate changes brought by artificial intelligence and other tech while protecting intellectual property rights.
Leaders in health tech are writing letters to clinicians to prevent fight things like physician burnout. Here’s the second in a series.
 
Patient-generated health data can be used to provide a clearer understanding of the benefits of wearable devices.
 
42 participants said they were likely to continue using the EHR-linked reminders.
 
The company said it uses DNA sequencing technology to predict and prevent cancer relapse.
But the FDA suggests that patients learn about their digital health tools.
 
What medical device flaws mean for healthcare organizations.
Digital voice assistant technology could help healthcare achieve increased compliance with treatment regimens.
Digital health can be useful for people in rural areas with limited access to in-person therapy.
 
Syndicated Studies
HRA® conducted a study to analyze the infectious disease landscape and scope for areas of opportunities for drug development, product marketing, and physician education. Use this syndicated study to strategically guide your entrance into this space and target infectious disease specialists.
Recent legislation has provided a faster path to market for biosimilars which are positioned to revolutionize the field of protein therapeutics. HRA® analyzed clinical, regulatory, and survey information on biosimilars to improve understanding and future expectations in the field. HRA® conducted an online survey with 160 Rheumatologists and Oncologists designed to yield insights into potential drivers of biosimilar prescribing. In addition, key insights from payers were included.
HRA® conducted a syndicated study to analyze the primary care physican (PCP) perceived involvement in cancer care. In this study, HRA® touched all facets of the relationship between PCPs and oncology from EMRs, early referrals and how to ensure both parties are informed to better the relationship between pharma, cancer centers,and PCPs.
Conferences
HRA is the premier provider of qualitative and quantitative research at healthcare conferences. HRA Rapid Results Conference offers clients the opportunity to get quick front line insights from their target audience from all phases of the product life cycle.
See where we'll be next year:
Full year conference calendar by therapeutic area
Full year conference calendar by month
About Us
Our People
HRA is a full-service market research company that operates with the core value of providing intimate, dedicated attention to the needs of our clients. With over 40 years of experience, we have the capabilities to leverage a panel of nearly 20,000 healthcare professionals and network of extensive relationships that allow us to uncover deeper insights into all multiple sectors of the healthcare industry.
Client Support & Business Development
Research and Analytics
Operational Innovation
Our Network
Professionals
Pharmacists
Payers
Patients
Partners
At Michael J. Hennessy Associates, Inc. our team has established reputation for offering timely, relevant, and practical information that meets the needs of our diverse audience. We provide healthcare professionals with the information and resources they need to maintain patient well-being. As a full-service healthcare communications company, we provide integrated communication products and services, education and research to the healthcare industry.
Copyright HRA Data Driven Intelligence 1974-2018 HRA Data Driven Intelligence, LLC. All rights Reserved.
^